Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

BACKGROUND: Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi-Zarchi, Mojgan, Allahqoli, Leila, Nehmati, Ameneh, Kashi, Abolfazl Mehdizadeh, Taghipour-Zahir, Shokouh, Alkatout, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045378/
https://www.ncbi.nlm.nih.gov/pubmed/32106837
http://dx.doi.org/10.1186/s12889-020-8371-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045378/
https://www.ncbi.nlm.nih.gov/pubmed/32106837
http://dx.doi.org/10.1186/s12889-020-8371-z

Ejemplares similares